Trevena (NASDAQ:TRVN) Stock Price Crosses Below Two Hundred Day Moving Average – Time to Sell?

Trevena, Inc. (NASDAQ:TRVN)’s stock price crossed below its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $2.24 and traded as low as $1.30. Trevena shares last traded at $1.30, with a volume of 667 shares trading hands.

Wall Street Analyst Weigh In

Separately, StockNews.com assumed coverage on Trevena in a research note on Wednesday. They issued a “sell” rating for the company.

Trevena Trading Down 4.4 %

The firm has a market capitalization of $1.12 million, a P/E ratio of -0.03 and a beta of 1.05. The firm has a 50 day moving average price of $1.67 and a 200-day moving average price of $2.24.

Trevena Company Profile

Trevena, Inc, a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV250, a G protein biased delta-opioid receptor agonist for the treatment of acute migraine; TRV734, a small molecule G protein biased ligand of the MOR for the treatment of moderate-to-severe acute and chronic pain; and TRV045, a novel S1P modulator for managing chronic pain.